These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 24191944

  • 1. Can (18)F-FDOPA PET/CT predict survival in patients with suspected recurrent glioma? A prospective study.
    Karunanithi S, Sharma P, Kumar A, Gupta DK, Khangembam BC, Ballal S, Kumar R, Kumar R, Bal C.
    Eur J Radiol; 2014 Jan; 83(1):219-25. PubMed ID: 24191944
    [Abstract] [Full Text] [Related]

  • 2. Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.
    Tripathi M, Sharma R, D'Souza M, Jaimini A, Panwar P, Varshney R, Datta A, Kumar N, Garg G, Singh D, Grover RK, Mishra AK, Mondal A.
    Clin Nucl Med; 2009 Dec; 34(12):878-83. PubMed ID: 20139821
    [Abstract] [Full Text] [Related]

  • 3. 18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.
    Ledezma CJ, Chen W, Sai V, Freitas B, Cloughesy T, Czernin J, Pope W.
    Eur J Radiol; 2009 Aug; 71(2):242-8. PubMed ID: 18511228
    [Abstract] [Full Text] [Related]

  • 4. F-18 FDG PET-CT for predicting survival in patients with recurrent glioma: a prospective study.
    Santra A, Kumar R, Sharma P, Bal C, Julka PK, Malhotra A.
    Neuroradiology; 2011 Dec; 53(12):1017-24. PubMed ID: 21739222
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prospective comparison of (99m)Tc-GH SPECT/CT and (18)F-FDOPA PET/CT for detection of recurrent glioma: a pilot study.
    Karunanithi S, Bandopadhyaya GP, Sharma P, Kumar A, Singla S, Malhotra A, Gupta DK, Bal C.
    Clin Nucl Med; 2014 Feb; 39(2):e121-8. PubMed ID: 23579970
    [Abstract] [Full Text] [Related]

  • 7. 18F-FDOPA PET and PET/CT accurately localize pheochromocytomas.
    Imani F, Agopian VG, Auerbach MS, Walter MA, Imani F, Benz MR, Dumont RA, Lai CK, Czernin JG, Yeh MW.
    J Nucl Med; 2009 Apr; 50(4):513-9. PubMed ID: 19289420
    [Abstract] [Full Text] [Related]

  • 8. Comparative diagnostic accuracy of contrast-enhanced MRI and (18)F-FDOPA PET-CT in recurrent glioma.
    Karunanithi S, Sharma P, Kumar A, Khangembam BC, Bandopadhyaya GP, Kumar R, Goenka A, Gupta DK, Malhotra A, Bal C.
    Eur Radiol; 2013 Sep; 23(9):2628-35. PubMed ID: 23624623
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas.
    Fueger BJ, Czernin J, Cloughesy T, Silverman DH, Geist CL, Walter MA, Schiepers C, Nghiemphu P, Lai A, Phelps ME, Chen W.
    J Nucl Med; 2010 Oct; 51(10):1532-8. PubMed ID: 20847166
    [Abstract] [Full Text] [Related]

  • 11. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.
    Chen W, Silverman DH, Delaloye S, Czernin J, Kamdar N, Pope W, Satyamurthy N, Schiepers C, Cloughesy T.
    J Nucl Med; 2006 Jun; 47(6):904-11. PubMed ID: 16741298
    [Abstract] [Full Text] [Related]

  • 12. 18F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional study.
    Patel CB, Fazzari E, Chakhoyan A, Yao J, Raymond C, Nguyen H, Manoukian J, Nguyen N, Pope W, Cloughesy TF, Nghiemphu PL, Czernin J, Lai A, Ellingson BM.
    J Neurooncol; 2018 Sep; 139(2):399-409. PubMed ID: 29679199
    [Abstract] [Full Text] [Related]

  • 13. 18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT.
    Karunanithi S, Sharma P, Kumar A, Khangembam BC, Bandopadhyaya GP, Kumar R, Gupta DK, Malhotra A, Bal C.
    Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):1025-35. PubMed ID: 23525498
    [Abstract] [Full Text] [Related]

  • 14. 13N-Ammonia PET/CT for detection of recurrent glioma: a prospective comparison with contrast-enhanced MRI.
    Khangembam BC, Sharma P, Karunanithi S, Singhal A, Das CJ, Kumar P, Julka PK, Bandopadhyaya GP, Kumar R, Malhotra A, Bal C.
    Nucl Med Commun; 2013 Nov; 34(11):1046-54. PubMed ID: 24025920
    [Abstract] [Full Text] [Related]

  • 15. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
    Kosztyla R, Chan EK, Hsu F, Wilson D, Ma R, Cheung A, Zhang S, Moiseenko V, Benard F, Nichol A.
    Int J Radiat Oncol Biol Phys; 2013 Dec 01; 87(5):1100-6. PubMed ID: 24161427
    [Abstract] [Full Text] [Related]

  • 16. Identify glioma recurrence and treatment effects with triple-tracer PET/CT.
    Li C, Yi C, Chen Y, Xi S, Guo C, Yang Q, Wang J, Sai K, Zhang J, Ke C, Chen F, Lv Y, Zhang X, Chen Z.
    BMC Med Imaging; 2021 May 31; 21(1):92. PubMed ID: 34059015
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of 3'-deoxy-3'-18F-fluorothymidine ([(18)F] FLT PET) in patients with recurrent malignant gliomas.
    Zhao F, Cui Y, Li M, Fu Z, Chen Z, Kong L, Yang G, Yu J.
    Nucl Med Biol; 2014 Sep 31; 41(8):710-5. PubMed ID: 24929963
    [Abstract] [Full Text] [Related]

  • 18. F-18 FDG PET-CT in patients with recurrent glioma: comparison with contrast enhanced MRI.
    Santra A, Kumar R, Sharma P, Bal C, Kumar A, Julka PK, Malhotra A.
    Eur J Radiol; 2012 Mar 31; 81(3):508-13. PubMed ID: 21353420
    [Abstract] [Full Text] [Related]

  • 19. Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy.
    Schwarzenberg J, Czernin J, Cloughesy TF, Ellingson BM, Pope WB, Grogan T, Elashoff D, Geist C, Silverman DH, Phelps ME, Chen W.
    Clin Cancer Res; 2014 Jul 01; 20(13):3550-9. PubMed ID: 24687922
    [Abstract] [Full Text] [Related]

  • 20. PET/CT using ¹⁸F-FDOPA provides improved staging of carcinoid tumor patients in a Canadian setting.
    Yakemchuk VN, Jager PL, Chirakal R, Reid R, Major P, Gulenchyn KY.
    Nucl Med Commun; 2012 Mar 01; 33(3):322-30. PubMed ID: 22183015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.